These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7712595)

  • 1. Eicosanoids and the immunology of cancer.
    Young MR
    Cancer Metastasis Rev; 1994 Dec; 13(3-4):337-48. PubMed ID: 7712595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha.
    Alleva DG; Burger CJ; Elgert KD
    Immunopharmacology; 1993; 25(3):215-27. PubMed ID: 8354638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
    Parhar RS; Lala PK
    J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic PGE2-releasing macrophages regulate Th1 and Th2 immune responses in mice treated with heat-killed BCG.
    Shibata Y; Henriksen RA; Honda I; Nakamura RM; Myrvik QN
    J Leukoc Biol; 2005 Dec; 78(6):1281-90. PubMed ID: 16204627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement in immunity of tumor bearing mice by immunization against prostaglandin E2.
    Young MR; Henderson S
    Immunol Commun; 1982; 11(5):345-56. PubMed ID: 6961100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of immune function and tumor growth inhibition by antibodies against prostaglandin E2.
    Young MR; Dizer M
    Immunol Commun; 1983; 12(1):11-23. PubMed ID: 6573300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal and splenic macrophage functions in the tumor-bearing host.
    Gardner TE; Naama H; Daly JM
    J Surg Res; 1995 Aug; 59(2):305-10. PubMed ID: 7637346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model.
    Bellamkonda K; Chandrashekar NK; Osman J; Selvanesan BC; Savari S; Sjölander A
    BMC Cancer; 2016 Jul; 16():425. PubMed ID: 27388564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoregulatory activities of eicosanoids in the rainbow trout (Oncorhynchus mykiss).
    Knight J; Rowley AF
    Immunology; 1995 Jul; 85(3):389-93. PubMed ID: 7558126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma.
    Young MR; Wheeler E; Newby M
    J Natl Cancer Inst; 1986 Apr; 76(4):745-50. PubMed ID: 3457207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids.
    Foley P; Kazazi F; Biti R; Sorrell TC; Cunningham AL
    Immunology; 1992 Mar; 75(3):391-7. PubMed ID: 1572689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.
    Alleva DG; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 May; 53(5):550-8. PubMed ID: 8388910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma.
    Alleva DG; Burger CJ; Elgert KD
    Scand J Immunol; 1994 Jan; 39(1):31-8. PubMed ID: 7904773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The modulation of human natural killer cell activity by prostaglandins.
    Bankhurst AD
    J Clin Lab Immunol; 1982 Feb; 7(2):85-91. PubMed ID: 6951051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the endotoxemia and endotoxin tolerance on the production of Th cytokines and macrophage interleukin-6: differential regulation of indomethacin.
    Chae BS
    Arch Pharm Res; 2002 Dec; 25(6):910-6. PubMed ID: 12510847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages.
    Coulombe F; Jaworska J; Verway M; Tzelepis F; Massoud A; Gillard J; Wong G; Kobinger G; Xing Z; Couture C; Joubert P; Fritz JH; Powell WS; Divangahi M
    Immunity; 2014 Apr; 40(4):554-68. PubMed ID: 24726877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention.
    Earnest DL; Hixson LJ; Alberts DS
    J Cell Biochem Suppl; 1992; 16I():156-66. PubMed ID: 1305681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors.
    Penglis PS; Cleland LG; Demasi M; Caughey GE; James MJ
    J Immunol; 2000 Aug; 165(3):1605-11. PubMed ID: 10903770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of macrophagic prostaglandin E2 synthesis by glioma cells.
    Nakano Y; Kuroda E; Kito T; Yokota A; Yamashita U
    J Neurosurg; 2006 Apr; 104(4):574-82. PubMed ID: 16619662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 production by human tumors. Defense mechanism against the host? A preliminary report.
    Attallah A; Lee JB; Ambrus JL; Ambrus CM; Karakousis C; Takita H
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):195-201. PubMed ID: 6584944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.